● Good AI PracticeOverviewSource LibraryArticles & ClausesApplicabilityInterpretationEvidence ReadinessAI GovernanceOperational FlowActors & ServicesUpdates & Assets
Regulations/Good AI Practice/Actors & Services
Actors & Services · Good AI Practice

Actors & Services for Good AI Practice.

This page maps the people and service routes around the regulation. It shows who needs which evidence view and where iFeed can support review, translation, training, or readiness work without overclaiming.

Source basis: Guiding principles for Good AI Practice in drug development and related lifecycle guidanceUse: evidence-readinessBoundary: not legal advice
Good AI Practice TRACE FDA/EMA GOOD AI PREMA/HMA AI LIFECFDA AI DRUG DEVEGMLP MEDICAL-DEV
/ Actors

Different owners need different evidence views.

Good AI Practice
Actor 01

AI product owner

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 02

data science lead

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 03

clinical/scientific owner

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 04

QA

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 05

regulatory strategy

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 06

safety/PV owner

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

Actor 07

model governance reviewer

This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for Good AI Practice.

/ Service fit

Where iFeed can help without overclaiming.

bridge work
Route 01

Source-to-evidence mapping

Convert source material into evidence objects, owners, gaps, and next actions.

Route 02

Checklist evaluation

Review completed readiness sheets and identify unclear or unsupported claims.

Route 03

Governance sprint

Create a practical two-week route for inventory, role mapping, evidence review, and update protocol.

Route 04

Training/workshop

Turn source reading into role-specific literacy and operational confidence.

/ Source anchors

Current public sources for Good AI Practice.

official first

These links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.

Official FDA page

FDA guiding principles for Good AI Practice in drug development

2026-01-14 · FDA page for common Good AI Practice principles in drug development.

open
Official EMA news

EMA and FDA common AI principles news

2026-01-14 · EU-facing publication context for the common principles.

open
Official EMA/HMA reflection paper

EMA/HMA AI in medicinal product lifecycle

2024-09-30 · Broader medicinal-product lifecycle reflection layer for AI use and governance.

open
Official regulator principles

FDA/Health Canada/MHRA GMLP principles

2021-10-27 · Ten guiding principles for Good Machine Learning Practice for medical device development.

open